Kynam Capital Management, LP
Position in TVTX — Travere Therapeutics, Inc.
CIK 1907884
PRINCETON, NJ
Position in TVTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$113,620,000
+$67,004,476 QoQ
Shares Held
2,000,000
+27.5% QoQ
Ownership
2.12%
of shares outstanding
% of Portfolio
6.28%
of 13F equity value
Holder Rank
#12
of 315 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Derivatives in TVTX
reported options exposure · as of Mar 31, 2026CallValue
$23,768,000
CallShares
800,000
PutValue
$1,631,079
PutShares
54,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kynam Capital Management, LP holds $1,765,169,848 across 29 Biotechnology names. TVTX ranks #7 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CLDX |
Celldex Therapeutics, Inc.
|
5,322,908 | $198,065,406 | |
| 2 | SNDX |
Syndax Pharmaceuticals Inc
|
8,050,959 | $175,993,963 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
2,922,335 | $169,875,333 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
3,667,097 | $141,916,653 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
2,890,059 | $124,012,431 | |
| 6 | VRDN |
Viridian Therapeutics, Inc.\DE
|
6,453,877 | $118,557,720 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
This page
|
2,000,000 | $113,620,000 | |
| 8 | BEAM |
Beam Therapeutics Inc.
|
2,840,792 | $97,495,981 |
All Filings in TVTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $113,620,000 | 2,000,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $46,615,524 | 1,569,018 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $23,768,000 | 800,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $1,631,079 | 54,900 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $19,788,347 | 517,884 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $22,698,475 | 949,727 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $22,802,226 | 1,540,691 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $32,305,280 | 1,802,750 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $31,403,905 | 1,802,750 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $19,187,438 | 1,371,511 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $16,618,036 | 2,021,659 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $15,420,000 | 2,000,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $17,980,000 | 2,000,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $134,994 | 15,100 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $8,560,067 | 957,502 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $22,344,652 | 1,454,730 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $35,165,251 | 1,563,595 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,792,621 | 418,099 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,268,202 | 416,729 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $29,927,708 | 1,235,151 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,443,556 | 870,918 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,652,477 | 182,103 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||